Remove Life Science Remove Pharma Companies Remove Pharma R&D Remove Vaccination
article thumbnail

Why VCs fell in love with pharma R&D in 2021

pharmaphorum

That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity. And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might. Start-ups move fast and break things.

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

In the last year alone, AI has been used for identifying novel targets 1 in areas like cardiomyopathy, generating novel antibodies 2 , and even designing newer modalities 3 like optimised mRNA vaccines for influenza. Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades.